{"id":13167,"date":"2022-03-04T12:18:20","date_gmt":"2022-03-04T06:48:20","guid":{"rendered":"https:\/\/www.rootsanalysis.com\/blog\/?p=13167"},"modified":"2026-07-23T21:41:01","modified_gmt":"2026-07-23T16:11:01","slug":"next-generation-complement-therapeutics-potential-life-changing-therapies-for-multiple-rare-disorders","status":"publish","type":"post","link":"https:\/\/www.rootsanalysis.com\/blog\/next-generation-complement-therapeutics-potential-life-changing-therapies-for-multiple-rare-disorders\/","title":{"rendered":"Next Generation Therapeutics: Novel Therapies for Rare Diseases"},"content":{"rendered":"\n

Since the approval of Soliris\u00ae in 2007, an anti-C5 antibody, the field of complement drug discovery has gained significant attention. Currently, nine complement therapeutics<\/a> are commercially available, while around 190 molecules are under development for various disease indications. Some of the complement therapeutics, namely Berinert\u00ae, Cinryze\u00ae, ORLADEYO\u00ae, Ruconest\u00ae and TAKHZYRO\u00ae were approved for the treatment of hereditary angioedema, by the US FDA and the EMA. These next generation therapeutics inhibit complement activation, thereby reducing tissue inflammation and dampening the adaptive immune response to foreign and tissue antigens.<\/p>\n\n\n\n

Complement Therapeutics \u2013 Current Market Landscape<\/strong><\/h2>\n\n\n\n

Currently, over 45 companies worldwide are actively engaged in the development of next generation complement therapeutics with enhanced efficacy. The market is characterized by a mix of well-established and small firms.<\/p>\n\n\n

\n
\"Next
Next Generation Complement Therapeutics – List of players<\/figcaption><\/figure>\n<\/div>\n\n\n

Want additional details on the pipeline?<\/h2>\n\n\n\n

The pipeline features more than 190 next generation complement therapeutics that are either marketed \/ are currently being evaluated across different phases of development. Majority of these are biologics and are being developed for the treatment of different disease conditions, including dermatological, genetic, hematological and vascular, immunological and inflammatory, infectious, neurological, ophthalmic, renal disorders.<\/p>\n\n\n

\n
\"The
Next Generation Complement Therapeutics – various distributions to understand the market<\/figcaption><\/figure>\n<\/div>\n\n\n

Broad Clinical Trial Landscape<\/strong><\/h2>\n\n\n\n

Till date, more than 870 clinical studies evaluating various complement-targeted therapeutics and involving nearly 2,430,000 patients enrolled across different centers \/ hospitals, have been initiated worldwide.<\/p>\n\n\n

\n
\"Next
Next Generation Complement Therapeutics – various trends of analysis (location of trial and year of registration)<\/figcaption><\/figure>\n<\/div>\n\n\n

Published Scientific Literature: Indicative of the Ongoing pace of Research in this Field<\/strong><\/h2>\n\n\n\n

Over the years, there has been a gradual increase in the number of publications related to next generation complement therapeutics. Majority of the publications were focused on therapeutics being investigated for the treatment of Hereditary Angioedema; such articles account for more than 40% of the total number of publications.<\/p>\n\n\n

\n
\"Next
Next Generation Complement Therapeutics – trends from analysis of extensive publication data<\/figcaption><\/figure>\n<\/div>\n\n\n

High Number of Patents are Suggestive of the Widespread Research in this Domain<\/strong><\/h2>\n\n\n\n

Several industry and non-industry players are involved in the development of next generation complement therapeutics. The field has seen a significant rise in the number of patents over the past few years, with AbbVie leading the way in terms of the total number of patents filed \/ granted.<\/p>\n\n\n

\n
\"High
Next Generation Complement Therapeutics – distribution by year, patent type, valuations<\/figcaption><\/figure>\n<\/div>\n\n\n

Billions of Dollars Invested in Venture Capital Funding<\/strong><\/h2>\n\n\n\n

The rising interest of investors within this upcoming segment is evident from the fact that nearly USD 1.1 billion was invested in venture capital funding by various industry and non-industry players, since 2017.<\/p>\n\n\n

\n
\"Billions
Next Generation Complement Therapeutics – analysis of investors funding in the domain<\/figcaption><\/figure>\n<\/div>\n\n\n

Future Evolution of Complement Therapeutics Market<\/strong><\/h2>\n\n\n\n

With the rising demand for novel therapeutic modalities, the next generation therapeutics market is anticipated to grow at an annualized rate of more than 15% between 2022 and 2035.<\/p>\n\n\n

\n
\"Future
Complement Therapeutics – high growth of the market in next decade is expected<\/figcaption><\/figure>\n<\/div>\n\n\n

Conclusion<\/strong><\/h3>\n\n\n\n

Owing to the fact that the complement system is a multidimensional innate immune surveillance system, more novel therapeutic targets are likely to be discovered in the future, with the active involvement of big pharma players as well as new pharma entrants. Further, with the encouraging clinical research efforts and broadening of disease focus, the complement inhibitors market<\/a> is poised to witness steady growth over the coming years.<\/p>\n\n\n\n

For more details, you can also download the SAMPLE REPORT<\/a> on complement therapeutics by Roots Analysis.<\/p>\n\n\n\n

Web: https:\/\/www.rootsanalysis.com\/<\/a><\/p>\n\n\n\n

LinkedIn: https:\/\/in.linkedin.com\/company\/roots-analysis<\/a><\/p>\n\n\n\n

Twitter: https:\/\/twitter.com\/RootsAnalysis<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

Since the approval of Soliris\u00ae in 2007, an anti-C5 antibody, the field of complement drug discovery has gained significant attention. Currently, nine complement therapeutics are commercially available, while around 190 molecules are under development for various disease indications. Some of the complement therapeutics, namely Berinert\u00ae, Cinryze\u00ae, ORLADEYO\u00ae, Ruconest\u00ae and TAKHZYRO\u00ae were approved for the treatment […]<\/p>\n","protected":false},"author":61,"featured_media":16731,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[767],"tags":[764,763,762,765,766,761],"class_list":["post-13167","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-complement-therapeutics","tag-complement-drug-discovery","tag-complement-inhibitors","tag-complement-system","tag-complement-therapeutics","tag-complement-therapeutics-market","tag-next-generation-complement-therapeutics"],"yoast_head":"\nThe Next Wave of Therapies Targeting Rare Immune Disorders<\/title>\n<meta name=\"description\" content=\"According to Roots Analysis, nine next generation therapeutics are commercially available, while around 190 molecules are under development\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.rootsanalysis.com\/blog\/next-generation-complement-therapeutics-potential-life-changing-therapies-for-multiple-rare-disorders\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"The Next Wave of Therapies Targeting Rare Immune Disorders\" \/>\n<meta property=\"og:description\" content=\"According to Roots Analysis, nine next generation therapeutics are commercially available, while around 190 molecules are under development\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.rootsanalysis.com\/blog\/next-generation-complement-therapeutics-potential-life-changing-therapies-for-multiple-rare-disorders\/\" \/>\n<meta property=\"og:site_name\" content=\"Blog\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/RootsAnalysis\/\" \/>\n<meta property=\"article:published_time\" content=\"2022-03-04T06:48:20+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-07-23T16:11:01+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2022\/03\/RootsAnalysis_FeaturedImage_003.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"150\" \/>\n\t<meta property=\"og:image:height\" content=\"150\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"Diksha Agarwal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@RootsAnalysis\" \/>\n<meta name=\"twitter:site\" content=\"@RootsAnalysis\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Diksha Agarwal\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/next-generation-complement-therapeutics-potential-life-changing-therapies-for-multiple-rare-disorders\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/next-generation-complement-therapeutics-potential-life-changing-therapies-for-multiple-rare-disorders\\\/\"},\"author\":{\"name\":\"Diksha Agarwal\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#\\\/schema\\\/person\\\/aa830c1670dfb9253cf536e634dcf390\"},\"headline\":\"Next Generation Therapeutics: Novel Therapies for Rare Diseases\",\"datePublished\":\"2022-03-04T06:48:20+00:00\",\"dateModified\":\"2026-07-23T16:11:01+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/next-generation-complement-therapeutics-potential-life-changing-therapies-for-multiple-rare-disorders\\\/\"},\"wordCount\":594,\"publisher\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/next-generation-complement-therapeutics-potential-life-changing-therapies-for-multiple-rare-disorders\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/wp-content\\\/uploads\\\/2022\\\/03\\\/RootsAnalysis_FeaturedImage_003.webp\",\"keywords\":[\"complement drug discovery\",\"complement inhibitors\",\"complement system\",\"complement therapeutics\",\"complement therapeutics market\",\"next-generation complement therapeutics\"],\"articleSection\":[\"Complement Therapeutics\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/next-generation-complement-therapeutics-potential-life-changing-therapies-for-multiple-rare-disorders\\\/\",\"url\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/next-generation-complement-therapeutics-potential-life-changing-therapies-for-multiple-rare-disorders\\\/\",\"name\":\"The Next Wave of Therapies Targeting Rare Immune Disorders\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/next-generation-complement-therapeutics-potential-life-changing-therapies-for-multiple-rare-disorders\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/next-generation-complement-therapeutics-potential-life-changing-therapies-for-multiple-rare-disorders\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/wp-content\\\/uploads\\\/2022\\\/03\\\/RootsAnalysis_FeaturedImage_003.webp\",\"datePublished\":\"2022-03-04T06:48:20+00:00\",\"dateModified\":\"2026-07-23T16:11:01+00:00\",\"description\":\"According to Roots Analysis, nine next generation therapeutics are commercially available, while around 190 molecules are under development\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/next-generation-complement-therapeutics-potential-life-changing-therapies-for-multiple-rare-disorders\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/next-generation-complement-therapeutics-potential-life-changing-therapies-for-multiple-rare-disorders\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/next-generation-complement-therapeutics-potential-life-changing-therapies-for-multiple-rare-disorders\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/wp-content\\\/uploads\\\/2022\\\/03\\\/RootsAnalysis_FeaturedImage_003.webp\",\"contentUrl\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/wp-content\\\/uploads\\\/2022\\\/03\\\/RootsAnalysis_FeaturedImage_003.webp\",\"width\":150,\"height\":150,\"caption\":\"This is a feature image for blog article Next Generation Complement Therapeutics at Roots Analysis\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/next-generation-complement-therapeutics-potential-life-changing-therapies-for-multiple-rare-disorders\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Next Generation Therapeutics: Novel Therapies for Rare Diseases\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#website\",\"url\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/\",\"name\":\"Blog\",\"description\":\"Roots Analysis\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#organization\",\"name\":\"Roots Analysis\",\"url\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/wp-content\\\/uploads\\\/2018\\\/11\\\/Roots-Analysis-High-Resolution-Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/wp-content\\\/uploads\\\/2018\\\/11\\\/Roots-Analysis-High-Resolution-Logo.jpg\",\"width\":205,\"height\":61,\"caption\":\"Roots Analysis\"},\"image\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/RootsAnalysis\\\/\",\"https:\\\/\\\/x.com\\\/RootsAnalysis\",\"https:\\\/\\\/www.instagram.com\\\/rootsanalysis\\\/\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/roots-analysis\\\/\",\"https:\\\/\\\/www.pinterest.it\\\/analysis1340\\\/\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UCwZF57vY1lnU0bNLej2zukg\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#\\\/schema\\\/person\\\/aa830c1670dfb9253cf536e634dcf390\",\"name\":\"Diksha Agarwal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/e93d630ef51920d937fa449aba4768dd24f32e6f87789bc6cf4155d1f962ea94?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/e93d630ef51920d937fa449aba4768dd24f32e6f87789bc6cf4155d1f962ea94?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/e93d630ef51920d937fa449aba4768dd24f32e6f87789bc6cf4155d1f962ea94?s=96&d=mm&r=g\",\"caption\":\"Diksha Agarwal\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"The Next Wave of Therapies Targeting Rare Immune Disorders","description":"According to Roots Analysis, nine next generation therapeutics are commercially available, while around 190 molecules are under development","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.rootsanalysis.com\/blog\/next-generation-complement-therapeutics-potential-life-changing-therapies-for-multiple-rare-disorders\/","og_locale":"en_US","og_type":"article","og_title":"The Next Wave of Therapies Targeting Rare Immune Disorders","og_description":"According to Roots Analysis, nine next generation therapeutics are commercially available, while around 190 molecules are under development","og_url":"https:\/\/www.rootsanalysis.com\/blog\/next-generation-complement-therapeutics-potential-life-changing-therapies-for-multiple-rare-disorders\/","og_site_name":"Blog","article_publisher":"https:\/\/www.facebook.com\/RootsAnalysis\/","article_published_time":"2022-03-04T06:48:20+00:00","article_modified_time":"2026-07-23T16:11:01+00:00","og_image":[{"width":150,"height":150,"url":"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2022\/03\/RootsAnalysis_FeaturedImage_003.webp","type":"image\/webp"}],"author":"Diksha Agarwal","twitter_card":"summary_large_image","twitter_creator":"@RootsAnalysis","twitter_site":"@RootsAnalysis","twitter_misc":{"Written by":"Diksha Agarwal","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.rootsanalysis.com\/blog\/next-generation-complement-therapeutics-potential-life-changing-therapies-for-multiple-rare-disorders\/#article","isPartOf":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/next-generation-complement-therapeutics-potential-life-changing-therapies-for-multiple-rare-disorders\/"},"author":{"name":"Diksha Agarwal","@id":"https:\/\/www.rootsanalysis.com\/blog\/#\/schema\/person\/aa830c1670dfb9253cf536e634dcf390"},"headline":"Next Generation Therapeutics: Novel Therapies for Rare Diseases","datePublished":"2022-03-04T06:48:20+00:00","dateModified":"2026-07-23T16:11:01+00:00","mainEntityOfPage":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/next-generation-complement-therapeutics-potential-life-changing-therapies-for-multiple-rare-disorders\/"},"wordCount":594,"publisher":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/#organization"},"image":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/next-generation-complement-therapeutics-potential-life-changing-therapies-for-multiple-rare-disorders\/#primaryimage"},"thumbnailUrl":"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2022\/03\/RootsAnalysis_FeaturedImage_003.webp","keywords":["complement drug discovery","complement inhibitors","complement system","complement therapeutics","complement therapeutics market","next-generation complement therapeutics"],"articleSection":["Complement Therapeutics"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.rootsanalysis.com\/blog\/next-generation-complement-therapeutics-potential-life-changing-therapies-for-multiple-rare-disorders\/","url":"https:\/\/www.rootsanalysis.com\/blog\/next-generation-complement-therapeutics-potential-life-changing-therapies-for-multiple-rare-disorders\/","name":"The Next Wave of Therapies Targeting Rare Immune Disorders","isPartOf":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/next-generation-complement-therapeutics-potential-life-changing-therapies-for-multiple-rare-disorders\/#primaryimage"},"image":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/next-generation-complement-therapeutics-potential-life-changing-therapies-for-multiple-rare-disorders\/#primaryimage"},"thumbnailUrl":"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2022\/03\/RootsAnalysis_FeaturedImage_003.webp","datePublished":"2022-03-04T06:48:20+00:00","dateModified":"2026-07-23T16:11:01+00:00","description":"According to Roots Analysis, nine next generation therapeutics are commercially available, while around 190 molecules are under development","breadcrumb":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/next-generation-complement-therapeutics-potential-life-changing-therapies-for-multiple-rare-disorders\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.rootsanalysis.com\/blog\/next-generation-complement-therapeutics-potential-life-changing-therapies-for-multiple-rare-disorders\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.rootsanalysis.com\/blog\/next-generation-complement-therapeutics-potential-life-changing-therapies-for-multiple-rare-disorders\/#primaryimage","url":"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2022\/03\/RootsAnalysis_FeaturedImage_003.webp","contentUrl":"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2022\/03\/RootsAnalysis_FeaturedImage_003.webp","width":150,"height":150,"caption":"This is a feature image for blog article Next Generation Complement Therapeutics at Roots Analysis"},{"@type":"BreadcrumbList","@id":"https:\/\/www.rootsanalysis.com\/blog\/next-generation-complement-therapeutics-potential-life-changing-therapies-for-multiple-rare-disorders\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.rootsanalysis.com\/blog\/"},{"@type":"ListItem","position":2,"name":"Next Generation Therapeutics: Novel Therapies for Rare Diseases"}]},{"@type":"WebSite","@id":"https:\/\/www.rootsanalysis.com\/blog\/#website","url":"https:\/\/www.rootsanalysis.com\/blog\/","name":"Blog","description":"Roots Analysis","publisher":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.rootsanalysis.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.rootsanalysis.com\/blog\/#organization","name":"Roots Analysis","url":"https:\/\/www.rootsanalysis.com\/blog\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.rootsanalysis.com\/blog\/#\/schema\/logo\/image\/","url":"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2018\/11\/Roots-Analysis-High-Resolution-Logo.jpg","contentUrl":"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2018\/11\/Roots-Analysis-High-Resolution-Logo.jpg","width":205,"height":61,"caption":"Roots Analysis"},"image":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/RootsAnalysis\/","https:\/\/x.com\/RootsAnalysis","https:\/\/www.instagram.com\/rootsanalysis\/","https:\/\/www.linkedin.com\/company\/roots-analysis\/","https:\/\/www.pinterest.it\/analysis1340\/","https:\/\/www.youtube.com\/channel\/UCwZF57vY1lnU0bNLej2zukg"]},{"@type":"Person","@id":"https:\/\/www.rootsanalysis.com\/blog\/#\/schema\/person\/aa830c1670dfb9253cf536e634dcf390","name":"Diksha Agarwal","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/e93d630ef51920d937fa449aba4768dd24f32e6f87789bc6cf4155d1f962ea94?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e93d630ef51920d937fa449aba4768dd24f32e6f87789bc6cf4155d1f962ea94?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e93d630ef51920d937fa449aba4768dd24f32e6f87789bc6cf4155d1f962ea94?s=96&d=mm&r=g","caption":"Diksha Agarwal"}}]}},"_links":{"self":[{"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/posts\/13167","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/users\/61"}],"replies":[{"embeddable":true,"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/comments?post=13167"}],"version-history":[{"count":6,"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/posts\/13167\/revisions"}],"predecessor-version":[{"id":22439,"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/posts\/13167\/revisions\/22439"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/media\/16731"}],"wp:attachment":[{"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/media?parent=13167"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/categories?post=13167"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/tags?post=13167"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}